Sihuan Financial Statements From 2010 to 2025
Sihuan Pharmaceutical financial statements provide useful quarterly and yearly information to potential Sihuan Pharmaceutical Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sihuan Pharmaceutical financial statements helps investors assess Sihuan Pharmaceutical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sihuan Pharmaceutical's valuation are summarized below:Sihuan Pharmaceutical Holdings does not presently have any fundamental trend indicators for analysis.
This module can also supplement various Sihuan Pharmaceutical Technical models . Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Check Sihuan Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sihuan Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sihuan financial statements analysis is a perfect complement when working with Sihuan Pharmaceutical Valuation or Volatility modules.
Sihuan |
Sihuan Pharmaceutical Holdings Company Return On Equity Analysis
Sihuan Pharmaceutical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sihuan Pharmaceutical Return On Equity | -0.0487 |
Most of Sihuan Pharmaceutical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sihuan Pharmaceutical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Sihuan Pharmaceutical Holdings has a Return On Equity of -0.0487. This is 99.8% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 84.29% lower than that of the firm.
Sihuan Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sihuan Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Sihuan Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sihuan Pharmaceutical competition to find correlations between indicators driving Sihuan Pharmaceutical's intrinsic value. More Info.Sihuan Pharmaceutical Holdings is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sihuan Pharmaceutical's earnings, one of the primary drivers of an investment's value.Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Sihuan Pink Sheet
If you are still planning to invest in Sihuan Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sihuan Pharmaceutical's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |